Human LOX1 ELISA Kit (ab212161)
Key features and details
- One-wash 90 minute protocol
- Sensitivity: 6.85 pg/ml
- Range: 15.625 pg/ml - 1000 pg/ml
- Sample type: Cell culture extracts, Cell culture supernatant, Cit plasma, EDTA Plasma, Hep Plasma, Serum, Tissue Extracts
- Detection method: Colorimetric
- Assay type: Sandwich (quantitative)
- Reacts with: Human
Overview
-
Product name
Human LOX1 ELISA Kit
See all LOX 1 kits -
Detection method
Colorimetric -
Precision
Intra-assay Sample n Mean SD CV% Serum 8 8.6% Inter-assay Sample n Mean SD CV% Serum 3 10.5% -
Sample type
Cell culture supernatant, Serum, Cell culture extracts, Tissue Extracts, Hep Plasma, EDTA Plasma, Cit plasma -
Assay type
Sandwich (quantitative) -
Sensitivity
6.85 pg/ml -
Range
15.625 pg/ml - 1000 pg/ml -
Recovery
Sample specific recovery Sample type Average % Range Cell culture supernatant 116 112% - 120% Serum 107 98% - 114% Cell culture extracts 98 97% - 99% Tissue Extracts 103 99% - 106% Hep Plasma 105 104% - 106% EDTA Plasma 109 108% - 111% Cit plasma 105 99% - 113% -
Assay time
1h 30m -
Assay duration
One step assay -
Species reactivity
Reacts with: Human
Does not react with: Cow -
Product overview
Human LOX1 ELISA Kit (ab212161) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of LOX1 protein in cell culture extracts, cell culture supernatant, cit plasma, edta plasma, hep plasma, serum, and tissue extracts. It uses our proprietary SimpleStep ELISA® technology. Quantitate Human LOX1 with NULL NULL sensitivity.
SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:
- Single-wash protocol reduces assay time to 90 minutes or less
- High sensitivity, specificity and reproducibility from superior antibodies
- Fully validated in biological samples
- 96-wells plate breakable into 12 x 8 wells stripsA 384-well SimpleStep ELISA® microplate (ab203359) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA® kits.
-
Notes
LOX1 is a receptor expressed on several cell types which mediate a variety of cellular processes. On vascular endothelial cell, LOX1 is involved in the internalization and degradation of oxidatively modified low density lipoprotein (oxLDL). In addition to this role, it is a receptor for HSP70 protein and is a part of antigen cross presentation in dendritic cells to native T-cells. It is also a receptor f advanced glycation end products, activated platelets, monocytes, apoptotic cells and Gram-negative and Gram-positive bacteria.
Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses. -
Platform
Pre-coated microplate (12 x 8 well strips)
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 1 x 96 tests 10X Human LOX1 Capture Antibody 1 x 600µl 10X Human LOX1 Detector Antibody 1 x 600µl 10X Wash Buffer PT (ab206977) 1 x 20ml 50X Cell Extraction Enhancer Solution (ab193971) 1 x 1ml 5X Cell Extraction Buffer PTR (ab193970) 1 x 10ml Antibody Diluent CPI - HAMA Blocker (ab193969) 1 x 6ml Human LOX1 Lyophilized Recombinant Protein 2 vials Plate Seals 1 unit Sample Diluent NS (ab193972) 1 x 50ml SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit Stop Solution 1 x 12ml TMB Development Solution 1 x 12ml -
Research areas
-
Function
Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria. -
Tissue specificity
Expressed at high level in endothelial cells and vascular-rich organs such as placenta, lung, liver and brain, aortic intima, bone marrow, spinal cord and substantia nigra. Also expressed at the surface of dendritic cells. Widely expressed at intermediate and low level. -
Involvement in disease
Note=Independent association genetic studies have implicated OLR1 gene variants in myocardial infarction susceptibility.
Note=OLR1 may be involved in Alzheimer disease (AD). Involvement in AD is however unclear: according to some authors (PubMed:12354387, PubMed:12810610 and PubMed:15976314), variations in OLR1 modify the risk of AD, while according to other (PubMed:15000751 and PubMed:15060104) they do not. -
Sequence similarities
Contains 1 C-type lectin domain. -
Domain
The cytoplasmic region is required for subcellular sorting on the cell surface.
The C-type lectin domain mediates the recognition and binding of oxLDL. -
Post-translational
modificationsThe intrachain disulfide-bonds prevent N-glycosylation at some sites.
N-glycosylated. -
Cellular localization
Cell membrane. Secreted. A secreted form also exists. - Information by UniProt
-
Alternative names
- C-type lectin domain family 8 member A
- CLEC8A
- hLOX 1
see all -
Database links
- Entrez Gene: 4973 Human
- Omim: 602601 Human
- SwissProt: P78380 Human
- Unigene: 412484 Human
Images
-
SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.
-
Background-subtracted data values (mean +/- SD) are graphed.
-
Background-subtracted data values (mean +/- SD) are graphed.
-
The concentrations of LOX1 were measured in duplicates, interpolated from the LOX1 standard curves and corrected for sample dilution. Undiluted samples are as follows: serum 100%, plasma (citrate) 100%, plasma (heparin) 100% and plasma (EDTA) 100%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 322 pg/mL in serum, 101 pg/mL in plasma (citrate), 106 pg/mL in plasma (heparin) and 165 pg/mL in plasma (EDTA).
-
Interpolated concentrations of native LOX1 in human Hela and placenta extract based on an 80 µg/mL and 500 µg/mL extract load.
The concentrations of LOX1 were measured in duplicate and interpolated from the LOX1 standard curve and corrected for sample dilution. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 927 pg/mL in Hela extract and 390 pg/mL in placenta extract.
-
Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 211 pg/mL with a range of 83.5 – 745 pg/mL.
-
Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean LOX1 concentration was determined to be 198 pg/mL with a range of 0 – 413 pg/mL.
-
To learn more about the advantages of recombinant antibodies see here.